Pharmacovigilance 2024

36th Pharmacovigilance 2024

“Ensuring safer drugs to market. Latest developments in PV & RMP”

06th – 07th November 2024, Hotel Kohinoor Continental, Mumbai, India

Virtue Insight is proud to announce that 36th Pharmacovigilance 2024 is happening on 06th – 07th November 2024, Hotel Kohinoor Continental, Mumbai, India.

DELEGATE REGISTRATION:

Please contact Email - E-mail - kavitha@virtueinsight.co.in or M: +91 9361957193 

Super Early Bird Discount Price (Valid till 13th Sep 24) - INR 14,000 + GST per delegate

Standard Price - INR 19,000 + GST per delegate

Conference Sponsor & Exhibition Stall – Should you wish to Sponsor, or purchase a Exhibition Stall (Booth) or a paid Speaker Slot, you can simply email your interest and queries

KEY SPEAKERS:

KHAUDEJA BANO, Vice President, Combination Product Quality, Amgen

MAYUR PARMAR, Deputy Collector, Prant Officer & SDM, Government of Gujarat

RAMESH JAGANNATHAN, VP Clinical Research & Pharmacovigilance, Bharat Serums and Vaccines

VIPIN SETHI, AVP, Global Head – Pharmacovigilance, Cadila

PRATIK SHAH, VP Medical Affairs, Bharat Serums and Vaccines

RAHUL GUPTA, Vice President, Regulatory Affairs, USV

VAIBHAV SALVI, Director & Head - Clinical Study Unit, India & South East Asia, Sanofi

SOURABH FULMALI, Global Medical Director – Respiratory, GSK

MUKESH GORI, Associate Director -ESP Management CMO & PS, Novartis

RAHUL SOMANI, Head- Global Pharmacovigilance, Alkem Laboratories

INDU NAMBIAR, Head Pharmacovigilance, Boehringer Ingelheim

JEROZE DALAL, Head of Clinical Operations, Governance & Risk Management, GSK

SANTOSH TAUR, Director Medical Affairs, Pfizer India & Chair, RWE Council of the ISCR

MILIND ANTANI, Leader, Pharma and Healthcare, Nishith Desai Associates

SAKSHI SHRIVASTAVA DESAI, Associate Director International Pharmacovigilance Strategy Realization, Johnson & Johnson

ANUJA JAWALE, Associate Director - RA/PV Strategic Engagements & Vendor Management, Organon

JAMAL BAIG, Multi Country Safety Head, Sanofi

RISHI JAIN, Country Medical Head, Novartis

ANJU AGARWAL, Global Director, Global Patient Safety, Advanz Pharma

SHIRAZ KANDAWALLA, Associate Director, Ferring Pharmaceuticals

DILIP PAWAR, Former Head - Medical Affairs & Pharmacovigilance, Unichem Laboratories

SRINIVASAN ACHARY, Associate Director, Cipla

ROSHAN PAWAR, Head Medical Affairs, Alkem Laboratories

KRUNAL DALAL, Head Medical Affairs, GSK

SADANAND KULKARNI, Head- Medical, Regulatory, Vigilance and Quality, Fresenius Kabi

SANKET NEWALE, Head Medical Affairs & Business Compliance, Wockhardt

SATISH SETHI, Head Global PV Operations & SERM Surveillance Operations, Glenmark

JYOTSNA PATWARDHAN, Cluster Head Clinical/PV QA at Africa, Middle East, Turkey & India, Novartis

MAYUR MAYBHATE, Head Medical Affairs, Alkem Laboratories

MARTINA GOMES, Head, Reg Affairs – CH, South Asia, Bayer

VIVEK GUPTA, Associate Director, Clinical/Medical Affairs/Outcomes Research Vendor Relationship, Organon

JOYDEEP SENGUPTA, Global Pharmacovigilance - Site Head, Sun Pharmaceuticals

SEERA DILEEP RAJU, Senior Manager - ML & AI, MSD

APARNA PRABHUNE, Assistant General Manager – Regulatory Affairs, Wockhardt

KAVITA LAMROR, Partner, RWE & Digital Transformation, MPartner, RWE & Digital Transformation, Maxis Clinical Sciences

GIRISH SANE, GM & Head Pharmacovigilance, Bristol Laboratories

RANJIT BARSHIKAR, CEO, QBD International, United Nations Adviser

SAKHARAM GARALE, Founder & CEO, Renovare Healthcare

KUSHAL SARDA, GM & Head - Medical Affairs, Clinical Research & PV, Shalina Healthcare

VISHWAS SOVANI, Founder Director, Pharmawisdom

VANSHIKA BRIJWANI, Manager Country Development Quality (CDQ), Novartis

PROTITI BAGCHI, Senior Manager - Digital Marketing | Customer experience | Product Strategy, Pfizer

CHAITANYA KULKARNI, GM Pharmacovigilance, Marksans Pharma

SUNIL NIGHOT, Manager, ICSR Quality, Kenvue (Division of J&J)

Plus more joining soon

FOCUSED AREAS:

Market Trends - Critique & Ways Forward

Challenges / Opportunities

Patient Safety

RMP / REMS

Safety & Signal Detection

Automation in PV

Regulatory

Impact of Technology AI, ML

Audits & Inspection

RWE / RWD

Outsourcing

WHO SHOULD ATTEND & WHO YOU’LL MEET:

CIOs, CEOs, CDOs, Vice Presidents, Presidents, Heads, Directors and Team Leaders from the following areas:

Pharmacovigilance Strategy, Drug Safety/Risk Management, Information and Clinical Data Management, Clinical Research, Research & Development, Product Safety/Assurance Assessment, Patient Safety & Outcomes Research & Data Analysis, Epidemiology project management, Regulatory Affairs and Compliance, Sales & Marketing, Biotech manufacturers,

From the following: Pharmaceutical organizations, Generic pharmaceutical companies, Contract research organizations, Patient recruitment companies

Get more from the event, with a broader scope bringing the whole communications value chain together. Enjoy and make the best out of our dedicated networking time, meet the leading international vendors showcasing the products of tomorrow in the co-located exhibition.